Skip to main content
VulnerabilityPublished Updated

CVE-2020-16241: Philips SureSigns VS4 · Improper Access Control

Affects Philips SureSigns VS4Source CVE Database V5

0

Not known to be exploited · CVSS 6.3 Medium.

Data as of 26 Oct 2026, 17:16 UTC

CVSS 3.1 base score
6.3Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 17% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:P/AC:H/PR:N/UI:N/S:C/C:L/I:L/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 21 Aug 2020

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
Philips SureSigns VS4Affected
  • =0
Fixed in–

AI-suggested

To mitigate CVE-2020-16241 effectively, European healthcare providers should implement strict physical security controls around Philips SureSigns VS4 devices to prevent unauthorized physical access. This includes securing device locations, restricting access to authorized medical staff only, and monitoring access logs if available. Network segmentation should be employed to isolate these devices from general hospital networks, reducing the risk of lateral movement if compromised. Regular audits and device inventory management will help identify vulnerable units. Until Philips releases a firmware patch, organizations should engage with Philips support to obtain guidance or interim mitigations. Additionally, staff training on the importance of device security and incident response plans tailored to medical device disruptions will enhance preparedness. Finally, integrating device monitoring solutions that can detect anomalous behavior or unauthorized access attempts can provide early warning signs of exploitation attempts.

Description

Philips SureSigns VS4, A.07.107 and prior does not restrict or incorrectly restricts access to a resource from an unauthorized actor.

References

Community reviews

Loading reviews…